Search results
Results from the WOW.Com Content Network
There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner of the world's current best-selling drug, cancer medicine Keytruda. Merck generates ...
Finally, add Dominion Energy (NYSE: D) to your list of smart dividend stocks to buy while its forward-looking dividend yield stands at 4.6%. You'd be hard-pressed to find much better than that ...
Even with that growth, the stock still trades at a fairly modest valuation. Its stock price is up 5.3% this year, compared with 16% growth for the S&P 500. Why isn't Merck's stock doing better in ...
Keytruda has been the best-selling medicine in the world since last year, when it generated $25 billion in sales. Merck's total revenue for the year was $60.1 billion, so Keytruda accounted for ...
The next few years might get bumpy for the pharmaceutical giant, but the longer term looks better.
For premium support please call: 800-290-4726 more ways to reach us
Merck & Co. (NYSE: MRK), a pharmaceutical giant known for its cancer immunotherapy drug Keytruda, has seen its stock surge 16.8% year-to-date. This impressive run follows aggressive buying by a ...
For premium support please call: 800-290-4726 more ways to reach us